Assessment of hepatic reserve for indication of hepatic resection: how I do it.
OBJECTIVE
Hepatic resection may result in liver failure in patients with cirrhotic livers. Preoperative evaluation of liver function in cirrhotic patients, to prevent postoperative liver failure, is very important.


METHODS
Sixteen patients with hepatocellular carcinoma in cirrhotic livers were enrolled in this study. Liver function was determined quantitatively by monoethylglycinexylidide (MEGX) formation from the metabolism of lidocaine. The whole liver volume and tumor volume were measured by computed tomographic volumetry. The volume of resected liver was recorded by water displacement. The relationship between liver function and remnant liver volume was determined.


RESULTS
A relationship between the percentage remnant liver volume and ratio of MEGX formation after hepatectomy was found. The regression equation was: (postoperative MEGX formation/preoperative MEGX formation) x 100% = (0.688 x percentage remnant liver volume + 0.179) x 100% (r (2) = 0.49). A relationship between MEGX formation after hepatectomy and the international ratio (INR) of prothrombin time was also found. The regression equation was INR = 1.99 - 0.01 x MEGX (r (2) = 0.30).


CONCLUSIONS
Post-hepatectomy liver function can be estimated for an individual patient by the appropriate regression equations. Prevention of post-hepatectomy liver failure for patients with cirrhotic livers is feasible.
Lee
Wei-Chen
WC
Department of General Surgery, Chang-Gung Memorial Hospital and Chang-Gung Medical School, 5 Fu-Hsing Street, Kwei-Shan Hsiang, Taoyuan, Taiwan, China.
Chen
Miin-Fu
MF
D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000378:metabolism; D008103:Liver Cirrhosis / Q000150:complications / Q000378:metabolism; D017093:Liver Failure / Q000209:etiology / Q000517:prevention & control; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D008297:Male; D018579:Patient Selection; D011183:Postoperative Complications; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D008012:Lidocaine; C001173:monoethylglycinexylidide